Chordia Therapeutics Inc. Chordia Therapeutics Inc.

Chordia Therapeutics Inc.

190A

Rank in Stocks #25959
Chordia Therapeutics Inc., a biotech company, engages in research and... Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
Share Price
$0.28765011
Last synced: 2026-11-13
Market Cap
$22.14M
Change (1 day)
2.10%
Change (1 year)
-56.98%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Chordia Therapeutics Inc. (190A)

Category

Healthcare
Operating Margin for Chordia Therapeutics Inc. (190A)
Operating Margin as of November 2026 TTM: 0.00%
According to Chordia Therapeutics Inc.'s latest financial reports, its current operating margin (TTM) is 0.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Chordia Therapeutics Inc. from 2021 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 0.00% 0.00%
2025 0.00% 0.00%
2024 0.00% -100.00%
2023 8.48% 0.00%
2022 0.00% -100.00%
2021 -73.46% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
-195.39% -
US
33.87% -
US
-116.04% -
US
25.57% -
AU
31.23% -
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.

Questions about Chordia Therapeutics Inc.'s operating margin

What was Chordia Therapeutics Inc.'s operating margin in 2025?

In 2025, Chordia Therapeutics Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.

How has Chordia Therapeutics Inc.'s operating margin changed since 2021?

From 2021 to 2025, Chordia Therapeutics Inc.'s operating margin was highest in 2023 (8.48%) and lowest in 2021 (-73.46%).

How does Chordia Therapeutics Inc.'s operating margin compare with similar companies?

Chordia Therapeutics Inc.'s operating margin (0.00%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 33.87%.